Erinacine A and related cyathane diterpenoids: Molecular diversity and mechanisms underlying their neuroprotection and anticancer activities.

Abstract

The presence of a fused 5/6/7 tricyclic core characterizes the group of cyathane diterpene natural products, that include more than 170 compounds, isolated from fungi such as Cyathus africanus and Hericium erinaceus. These compounds have a common biosynthetic precursor (cyatha-3,12-diene) and can be produced bio- or hemi-synthetically, or via total syntheses. Cyathane diterpenes display a range of pharmacological properties, including anti-inflammatory (possibly through binding to the iNOS protein) and neuroprotective effects. Many cyathanes like cyahookerin C, cyathin Q and cyafranines B and G can stimulate neurite outgrowth in cells, whereas conversely a few molecules (such as scabronine M) inhibit NGF-stimulated neurite outgrowth. The main anticancer cyathanes are erinacine A and cyathins Q and R, with a capacity to trigger cancer cell death dependent on the production of reactive oxygen species (ROS). These compounds, active both in vitro and in vivo, activate different signaling pathways in tumor cells to induce apoptosis (and autophagy) and to upregulate the expression of several proteins implicated in the organization and functioning of the actin cytoskeleton. An analysis of the functional analogy between erinacine A and other natural products known to interfere with the actin network in a ROS-dependent manner (notably cucurbitacin B) further supports the idea that erinacine A functions as a perturbator of the cytoskeleton organization. Collectively, we provide an overview of the molecular diversity of cyathane diterpenes and the main mechanisms of action of the lead compounds, with the objective to encourage further research with these fungal products. The anticancer potential of erinacine A deserves further attention but it will be necessary to better characterize the implicated targets and signaling pathways.

• Authors: Christian Bailly, Jin-Ming Gao
• Journal: Pharmacological research (Pharmacol Res) Vol. 159 Pg. 104953 (09 2020) ISSN: 1096-1186 [Electronic] Netherlands
• PMID: 32485283 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
• Copyright: Copyright © 2020 Elsevier Ltd. All rights reserved.

Chemical References

• Anti-Inflammatory Agents
• Antineoplastic Agents, Phytogenic
• Diterpenes
• Neuroprotective Agents
• cyathane
• erinacine A

Topics

• Actin Cytoskeleton (drug effects, metabolism, pathology)
• Animals
• Anti-Inflammatory Agents (adverse effects, therapeutic use)
• Antineoplastic Agents, Phytogenic (adverse effects, therapeutic use)
• Diterpenes (adverse effects, therapeutic use)
• Humans
• Neoplasms (drug therapy, metabolism, pathology)
• Nervous System Diseases (drug therapy, metabolism, pathology)
• Neurons (drug effects, metabolism, pathology)
• Neuroprotective Agents (adverse effects, therapeutic use)
• Signal Transduction